Immunisation schedule Victoria

Infants and children – July 2018

*Live attenuated vaccine Medical risk factors

Age Disease Vaccine brand® Reconstitute Site given Route given Notes
Birth Hepatitis B H-B-Vax-II 7 Anterolateral IM Give preferably within 24 hours of birth
Paediatric or thigh May be given up to 7 days after birth
Engerix-B
Paediatric
2 months Diphtheria-tetanus-pertussis, Infanrix hexa 3 Anterolateral IM
(from 6 weeks) poliomyelitis-hepatitis B- thigh
and Haemophilus influenzae type b
4 months
Pneumococcal Prevenar 13 7 Anterolateral IM
thigh
Rotavirus Rotarix* 7 Mouth Oral 1st dose must be given before 15 weeks of age
2nd dose must be given before 25 weeks of age
6 months Diphtheria-tetanus-pertussis- Infanrix hexa 3 Anterolateral IM Give with an 8-week interval after dose 2 of Infanrix hexa
poliomyelitis-hepatitis B- thigh at minimum age of 24 weeks.
Haemophilus influenzae type b

6 months of age Pneumococcal Prevenar 13 7 Anterolateral IM See current Handbook for children with a medical risk
premature baby < thigh
28 weeks gestation
or with medical risk
factor
6 months to <5 years - Influenza As supplied 7 Anterolateral IM Annually. In children aged 6 months to less than 9 years
all infants and children thigh < 12 of age in the first year of administration, give 2 doses a
months minimum of 1 month apart
of age Give 0.25ml dose from 6 months to under 3 years of age

Immunisation Section – Department of Health and Human Services: 1300 882 008 National HPV Register: 1800 478 734
Australian Immunisation Register: 1800 653 809 SAEFVIC - Victoria’s vaccine safety service: 1300 882 924 #1

This schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended.
For additional information refer to the online edition of the handbook: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
Immunisation schedule Victoria. Infants and children – July 2018 (continued)
*Live attenuated vaccine Medical risk factors

Age Disease Vaccine brand® Reconstitute Site given Route given Notes
12 months Measles-mumps- Priorix* or 3 Anterolateral Priorix SC /IM,
rubella M-M-R-II* thigh M-M-R-II SC
Meningococcal Nimenrix 3 Deltoid IM
ACWY
Pneumococcal Prevenar 13 7 Deltoid IM

12 months of age premature Hepatitis B H-B-Vax-II 7 Deltoid IM single booster dose

Paediatric or

Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne.

baby < 32 weeks gestation or

© State of Victoria, Department of Health and Human Services, July 2018. (1805038)
< 2000g birthweight Engerix-B
Paediatric
18 months Measles-mumps- PriorixTetra* or 3 Deltoid PriorixTetra Current handbook recommends 2nd dose of Varilrix®/
rubella-varicella ProQuad* SC/IM, Varivax® to reduce incidence of 'breakthrough' varicella.
(chickenpox) Proquad SC This MUST be on prescription. Minimum 1 month interval
for 2 live vaccines.

Diphtheria-tetanus- Infanrix or 7 Deltoid IM

pertussis Tripacel

Haemophilus ActHIB 3 Anterolateral IM

influenzae type b thigh
4 years Diphtheria- Infanrix IPV or 7 Deltoid IM
tetanus- pertussis- Quadracel
poliomyelitis
4-5 years of age with Pneumococcal Pneumovax 23 7 Deltoid IM See current Handbook for recommended additional
medical risk factor doses for children at increased risk

BCG for eligible infants and Tuberculosis As supplied BCG* for infants and children under 5 years of age
children travelling to TB endemic countries

5 years of age and over with Influenza Influenza 7 Deltoid IM If less than 9 years of age in the first year of
medical risk factor administration, give 2 doses a minimum of 1 month
apart

Intramuscular injection (IM) Needle size Angle of needle insertion Subcutaneous injection (SC) Needle size Angle of needle insertion
Infants and children 23G/25G, 25mm length 90˚ to skin plane In all persons 25G/26G, 16mm length 45˚ to skin plane
Pre-term babies and very small babies 25G/23G, 16mm length 90˚ to skin plane

This schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended.
For additional information refer to the online edition of the handbook: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
Immunisation schedule Victoria
Adolescents – July 2018

*Live attenuated vaccine Medical risk factors

Age Disease Vaccine brand® Reconstitute Site given Route given Notes

Year 7 Secondary school Human Gardasil 9 7 Deltoid IM 2 dose course (0, 6-12m) under 15 years & 3 dose course

Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne.

© State of Victoria, Department of Health and Human Services, July 2018. (1805038)
(or age equivalent, 12-13 papillomavirus (0, 2m, 6m) if 15 years and over. Major
years of age) (HPV) immunocompromising conditions require a 3 dose course.

Diphtheria- Boostrix 7 Deltoid IM

tetanus-pertussis

Year 10 Secondary School Meningococcal Menactra 7 Deltoid IM Time limited program ceases 31 December 2018.
(or age equivalent) ACWY

15 years of age and over Influenza As supplied 7 Deltoid IM Annually

Aboriginal & Torres Strait
Islanders

15 years of age and over Pneumococcal Pneumovax 23 7 Deltoid IM See current Handbook for recommended additional
Aboriginal & Torres Strait doses for people at increased risk
Islanders with a medical
risk factor

Young people with a Influenza As supplied 7 Deltoid IM Annually. See current Handbook for identification of
medical risk factor people at increased risk

Intramuscular injection (IM) Needle size Angle of needle insertion Subcutaneous injection (SC) Needle size Angle of needle insertion
Adolescent 23G/25G, 25mm length 90˚ to skin plane In all persons 25G/26G, 16mm length 45˚ to skin plane
Very large adolescent 23G/25G, 38mm length 90˚ to skin plane

This schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended.
For additional information refer to the online edition of the handbook: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
Immunisation schedule Victoria
Adults – July 2018

*Live attenuated vaccine Medical risk factors

Age Disease Vaccine brand® Reconstitute Site given Route given Notes
Aboriginal & Torres Strait Pneumococcal Pneumovax 23 7 Deltoid IM See current Handbook for recommended additional doses for

Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne.

Islanders with a medical people at increased risk

© State of Victoria, Department of Health and Human Services, July 2018. (1805038)
risk factor
Aboriginal & Torres Strait Influenza As supplied 7 Deltoid IM Annually
Islanders
Hepatitis B

Pregnant women Influenza As supplied 7 Deltoid IM At any stage of pregnancy

Diphtheria- Adacel or 7 Deltoid IM Pregnant women from 28 weeks gestation during every pregnancy
tetanus- Boostrix Partners of women who are at least 28 weeks pregnant if the
pertussis partner has not received a pertussis booster in the last ten years.
Parents/guardians of a baby under 6 months of age and they
have not received a pertussis booster in the last 10 years.
People with a medical Influenza As supplied 7 Deltoid IM Annually. See current Handbook for identification of people at
risk factor increased risk
From 50 years of age Pneumococcal Pneumovax 23 7 Deltoid IM See current Handbook for recommended additional doses for
Aboriginal & Torres Strait people at increased risk
Islanders
From 65 years Influenza As supplied 7 Deltoid IM Annually. Use high-immunogenicity formulations
Pneumococcal Pneumovax 23 7 Deltoid IM See current Handbook for recommended additional doses for
people at increased risk
70 years or from 71 to 79 Shingles Zostavax 3 Deltoid SC Single dose unless contra-indicated
years (until the end of 2021) (Herpes Zoster)

Intramuscular injection (IM) Needle size Angle of needle insertion Subcutaneous injection (SC) Needle size Angle of needle insertion
Adults 23G/25G, 25mm length 90˚ to skin plane In all persons 25G/26G, 16mm length 45˚ to skin plane
Very large adult 23G/25G, 38mm length 90˚ to skin plane

This schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended.
For additional information refer to the online edition of the handbook: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home
Immunisation schedule Victoria
Additional at risk groups – July 2018

*Live attenuated vaccine Medical risk factors

Group Disease Vaccine brand® Reconstitute Site given Route given Notes
Women planning pregnancy Measles-mumps- Priorix* 3 Deltoid Priorix SC/IM, Rubella non-immune women planning pregnancy or shortly
or after delivery rubella M-M-R-II SC after delivery

Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne.

**Vulnerable citizens Age appropriate As supplied As applicable As As applicable Eligible for NIP and Victorian funded immunisation programs

© State of Victoria, Department of Health and Human Services, July 2018. (1805038)
vaccine catch-up applicable
Hepatitis B vaccine for Hepatitis B Engerix-B 7 Deltoid IM All non immune Aboriginal and Torres Strait Islander people
eligible people at risk (paediatric/adult) Household contacts or sexual partners of people living with
hepatitis B infection
People who inject drugs or are on opioid substitution therapy
People living with hepatitis C
Men who have sex with men
People living with HIV
Prisoners and remandees
People no longer in a custodial setting who commenced but did
not complete the vaccine course while in custody
People from endemic countries and who arrived in Australia in
the last 10 years. (Priority countries include China, Philippines,
Malaysia, Vietnam, Afghanistan, Thailand, South Korea, Myanmar
(Burma) Indonesia, Singapore, Hong Kong, Taiwan and Cambodia)
**Rabies vaccine for eligible Rabies As supplied 3 Deltoid IM Volunteer handler of Australian bats in Victoria for the primary
people at risk course
Post exposure prophylaxis
Men who have sex with men Meningococcal Menactra 7 Deltoid IM Time limited program to finish on 31 December 2018
Human Gardasil 7 Deltoid IM Time limited program to finish on 31 December 2018
Papillomavirus
Hepatitis A Havrix 1440 7 Deltoid IM Time limited program to finish on 31 December 2018
People who have injected Hepatitis A Havrix 1440 7 Deltoid IM Time limited program to finish on 31 December 2018
drugs in the past 12 months

Intramuscular injection (IM) Needle size Angle of needle insertion Subcutaneous injection (SC) Needle size Angle of needle insertion
In all persons 23G/25G, 25mm length 90˚ to skin plane In all persons 25G/26G, 16mm length 45˚ to skin plane
Pre-term babies & very small babies 25G/23G, 16mm length 90˚ to skin plane
Very large person 23G/25G, 38mm length 90˚ to skin

This schedule is intended as a guide only and complete consultation with The Australian Immunisation Handbook is recommended.
For additional information refer to the online edition of the handbook: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home